Home > Journals > Medicine > European Journal of Dermatology > Full text
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
European Journal of Dermatology
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
  Printable version
  Version PDF

Further delineation of the hypotrichosis-deafness syndrome


European Journal of Dermatology. Volume 15, Number 6, 437-8, November-December 2005, Genes and skin


Summary  

Author(s) : Maurice AM Van Steensel, M Van Geel, PM Steijlen , Department of Dermatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands.

Summary : We recently delineated a novel disorder characterized by hypotrichosis, nail dystrophy and sensorineural deafness and caused by a missense mutation in GJB2 (connexin26). The patient, a girl, was two years old when we first saw her. We had the opportunity to re-examine her at four years of age and found that the phenotype had changed appreciably. The hypotrichosis was less pronounced, but the nail dystrophy had worsened. Intriguingly, the phenotype now included a mucositis and skin lesions identical to those found in erythrokeratodermia variabilis. There is now a considerable overlap with other gap junction disorders and we propose that some cases of erythrokeratodermia variabilis without mutations in either GJB3 or GJB4 but with deafness may be caused by mutations in GJB2. This is the first description of the evolution of a gap junction disease over time and we note that follow-up of patients suffering from gap junction skin disorders is necessary to fully delineate the phenotypes caused by mutations in gap junction genes.

Keywords : erythrokeratoderma, gap junction, connexin, hypotrichosis-deafness syndrome

Pictures

ARTICLE

Auteur(s) : Maurice AM Van Steensel, M Van Geel, PM Steijlen

Department of Dermatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands

accepté le 22 Juin 2005

In the August 2004 issue of the Journal of Investigative Dermatology we described a two year-old girl whom we first saw in 2002 with bilateral sensory deafness, mild nail dystrophy and mild hypotrichosis. At the time, the clinical phenotype resembled that of Clouston syndrome prompting us to analyse the skin expressed gap junction genes for mutations. In GJB2 we found a heterozygous C to G transversion in codon 14 resulting in the substitution of the asparagine by a lysine (N14K) [1]. At the time, there were no other associated symptoms. In particular, an erythrokeratoderma or a mucositis as described by Brown et al., associated with a F142L substitution in GJB2 [2], were not present and we therefore considered the disease as distinct from other gap junction diseases of the skin.Recently, we had the opportunity to examine the patient again. During the past two years, the phenotype had progressively changed. According to the mother, she now showed red spots on the legs that migrated during the day, accompanied by slight scaling. The lesions were slightly pruritic, had been diagnosed as eczema and treated as such using local steroids, to no avail. In addition, the oral mucosa, and the lips in particular, were red and painful, with crusting. This had been attributed to thumb sucking and treated with zinc oxide paste, which had not resulted in improvement. The vaginal mucosa was said to be inflamed. The patient was again referred to our department for therapy. Upon examination, we noted pronounced redness with crusting and fissuring of both lips as well as fissuring of the buccal mucosa ( (figure 1) ). There was no peridontitis; the tongue and teeth appeared normal. Hypotrichosis of the scalp was still present but it was less pronounced than at the initial presentation two years ago. Eyelashes and eyebrows were normal. In contrast to earlier findings, the fingernails were severely dystrophic and dyschromic with pronounced scaling and fracturing of the nail plates ( (figure 2) ). The toenails showed similar abnormalities. On the lower legs, figurated and sometimes slightly elevated erythematous patches with slight white scaling were visible. The lesions were sharply demarcated ( (figures 3 A,B) ). Further examination showed vulvar redness but no other abnormalities were found. The child communicated using sign language. As she was very fearful of additional procedures, we chose not to perform any biopsies.Our re-evaluation of the development of hypotrichosis-deafness syndrome shows that the phenotype is dynamic. Whereas hypotrichosis, thin nails and deafness were the presenting symptoms, during the past two years additional abnormalities have developed. The mucositis resembles that found in the patient with the F142L mutation although it is less severe. It would be of interest to examine patients with other GJB2 associated skin diseases for the presence of mucositis. Like deafness, it may be a symptom shared by phenotypes associated with mutations in GJB2.The genotype-phenotype correlation of diseases associated with mutations in GJB2 may not be as pronounced as was previously thought, but the lack of follow-up on patients makes this question difficult to answer. Of particular interest in this regard is the presence of erythrokeratodermia variabilis (EKV)-like skin lesions in our patient. To our knowledge, similar abnormalities have not been reported in association with GJB2 mutations. The erythrokeratodermia that is associated with keratitis-ichthyosis-deafness syndrome is characterized by a very pronounced cobblestone-like hyperkeratosis, in contrast to that of EKV, which tends to be fine and white. While the finding that a GJB2 mutation can cause a disturbance of keratinization is not unexpected, the fact that it looks like EKV is intriguing. In our view, it raises the possibility that skin symptoms in gap junction disease may actually share a common pathogenetic mechanism that may not depend completely on the identity of the gap junction gene that is affected. Other mutations in GJB2, notably N54K and G59R [3, 4], are associated with a palmoplantar keratoderma. Hence, it may be that the erythrokeratoderma we observe in our patient is unique to N14K and incidentally resembles that found in EKV. A careful follow up of patients with skin diseases caused by mutations in GJB2 should help in resolving this issue.Finally, our results indicate that it would be of interest to examine patients with EKV not associated with mutations in either GJB3 or GJB4 for the presence of mutations in GJB2. Genetic heterogeneity is a feature of EKV [5, 6] and while incorrect clinical diagnoses may account for a sizeable portion of such cases, there is now a distinct possibility that mutations in GJB2 may mimic EKV.

Acknowledgements

This work was supported by Barrier Therapeutics NV and by the Pachyonychia Congenita Foundation.

References

1 Van Steensel MA, Steijlen PM, Bladergroen RS, et al. A Phenotype Resembling the Clouston Syndrome with Deafness Is Associated with a Novel Missense GJB2 Mutation. J Invest Dermatol 2004; 123: 291-3.

2 Brown CW, Levy ML, Flaitz CM, et al. A novel GJB2 (connexin 26) mutation, F142L, in a patient with unusual mucocutaneous findings and deafness. J Invest Dermatol 2003; 121: 1221-3.

3 Kelsell DP, Wilgoss AL, Richard G, et al. Connexin mutations associated with palmoplantar keratoderma and profound deafness in a single family. Eur J Hum Genet 2000; 8: 469-72.

4 Richard G, Brown N, Ishida-Yamamoto A, et al. Expanding the phenotypic spectrum of Cx26 disorders: Bart-Pumphrey syndrome is caused by a novel missense mutation in GJB2. J Invest Dermatol 2004; 123: 856-63.

5 Van Geel M, Van Steensel MA, Steijlen PM. Connexin 30.3 (GJB4) is not required for normal skin function in humans. Br J Dermatol 2002; 147: 1275-7.

6 van Steensel MA. Gap junction diseases of the skin. Am J Med Genet 2004; 131C: 12-9.


 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]